Nobuyuki Sasaki Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2002

Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuyuki Sasaki Research Topics

Disease

11	Stroke (Strokes) 06/2020 - 05/2013
5	Neoplasms (Cancer) 07/2022 - 07/2003
4	Paresis (Hemiparesis) 06/2020 - 05/2013
3	Alzheimer Disease (Alzheimer's Disease) 09/2004 - 06/2002
2	Cognitive Dysfunction 01/2023 - 09/2017
2	Aphasia (Dysphasia) 01/2017 - 08/2004
2	Neoplasm Metastasis (Metastasis) 01/2005 - 02/2004
2	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2002 - 01/2002
1	Fatigue 01/2023
1	COVID-19 01/2023
1	Cerebral Hemorrhage 12/2022
1	Osteosarcoma (Osteogenic Sarcoma) 07/2022
1	Spinal Cord Diseases 01/2022
1	Chondrosarcoma 11/2020
1	Spontaneous Fractures (Pathological Fracture) 11/2020
1	Muscle Spasticity (Spastic) 05/2018
1	Brain Injuries (Brain Injury) 09/2017
1	Infections 12/2016
1	Intervertebral Disc Displacement (Herniated Disc) 01/2011
1	Pain (Aches) 01/2011
1	Peripheral Nerve Injuries 01/2011
1	Squamous Cell Carcinoma of Head and Neck 01/2005
1	Diabetic Angiopathies (Diabetic Angiopathy) 02/2004
1	Melanoma (Melanoma, Malignant) 02/2004
1	Lymphoma (Lymphomas) 07/2003
1	Alcoholism (Alcohol Abuse) 05/2003
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 06/2002

Drug/Important Bio-Agent (IBA)

4	Receptor for Advanced Glycation End ProductsIBA 01/2005 - 07/2003
4	Advanced Glycation End ProductsIBA 09/2004 - 06/2002
3	Type A Botulinum Toxins (Botox)FDA Link 05/2018 - 06/2017
2	incobotulinumtoxinA FDA Link 01/2018 - 06/2017
2	salicylhydroxamic acid (SHAM)IBA 03/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2005 - 02/2004
2	GlyceraldehydeIBA 09/2004 - 02/2004
1	Serine (L-Serine)FDA Link 01/2020
1	Amino Acids FDA Link 01/2020
1	Heparin (Liquaemin)FDA LinkGeneric 12/2016
1	MitogensIBA 01/2011
1	Neuroprotective AgentsIBA 01/2011
1	Phosphotransferases (Kinase)IBA 01/2011
1	Erythropoietin FDA Link 01/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011
1	OligodeoxyribonucleotidesIBA 01/2005
1	Neutralizing AntibodiesIBA 02/2004
1	glycolaldehydeIBA 02/2004
1	S100 Proteins (S 100 Protein)IBA 07/2003
1	Tumor Biomarkers (Tumor Markers)IBA 07/2003
1	S100A12 ProteinIBA 07/2003
1	EpitopesIBA 05/2003
1	Amyloid beta-PeptidesIBA 06/2002
1	PrionsIBA 06/2002
1	PalmitatesIBA 04/2002
1	Retinaldehyde (Retinal)IBA 01/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2002

Therapy/Procedure

11	Transcranial Magnetic Stimulation 01/2023 - 05/2013
8	Therapeutics 06/2020 - 02/2004
2	Operative Surgical Procedures 07/2022 - 11/2020
2	Speech Therapy (Therapy, Speech) 01/2017 - 08/2004
1	Arthrodesis 07/2022
1	Drug Therapy (Chemotherapy) 07/2022
1	Bone Transplantation (Bone Grafting) 11/2020
1	Occupational Therapy (Therapy, Occupational) 06/2020
1	Cognitive Training 09/2017
1	Intra-Arterial Infusions 12/2016